Research programme: Huntington's disease therapy - NeuroSearch

* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

Originator
NeuroSearch

Class

Mechanism of Action
Ion channel antagonists

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No

Highest Development Phases

Discontinued
Huntington's disease

Most Recent Events

28 Sep 2011
Research programme: Huntington's disease therapy - NeuroSearch is available for licensing as of 28 Sep 2011. http://neurosearch.com

30 Mar 2011
Preclinical development is ongoing in Denmark

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Login
with a username/password associated to an account with a valid subscription